Adenoviral vectors as novel vaccines for influenza.
OBJECTIVES: Influenza is a viral respiratory disease causing seasonal epidemics, with significant annual illness and mortality. Emerging viruses can pose a major pandemic threat if they acquire the capacity for sustained human-to-human transmission. Vaccination reduces influenza-associated mortality...
Auteurs principaux: | Coughlan, L, Mullarkey, C, Gilbert, S |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2015
|
Documents similaires
-
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
par: Lynda Coughlan
Publié: (2020-05-01) -
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
par: Jingao Guo, et autres
Publié: (2018-07-01) -
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
par: Ekramy E. Sayedahmed, et autres
Publié: (2020-10-01) -
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
par: Ewer (nee Russell), K, et autres
Publié: (2017) -
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
par: Katie Ewer, et autres
Publié: (2017-12-01)